期刊文献+
共找到6篇文章
< 1 >
每页显示 20 50 100
依据ADRA2A和MDGA2基因多态性指导米那普仑治疗抑郁症的疗效观察 被引量:4
1
作者 钱兴山 张新风 +4 位作者 涂哲明 涂清芬 彭海燕 邓小鹏 刘波 《药物流行病学杂志》 CAS 2020年第10期675-679,720,共6页
目的:在药物基因检测确定ADRA2A和MDGA2的基因多态性基础上,对服用米那普仑治疗的抑郁症患者实施个体化治疗,探讨临床疗效与安全性。方法:抑郁症患者随机分为研究组(80例)与对照组(87例)。研究组患者经药物基因检测,选择55例ADRA2A基因... 目的:在药物基因检测确定ADRA2A和MDGA2的基因多态性基础上,对服用米那普仑治疗的抑郁症患者实施个体化治疗,探讨临床疗效与安全性。方法:抑郁症患者随机分为研究组(80例)与对照组(87例)。研究组患者经药物基因检测,选择55例ADRA2A基因突变杂合型(CG)和MDGA2基因突变型(CC)作为"推荐使用"患者入组;对照组经三级医师查房经验用药,纳入68例。两组均给予米那普仑片治疗。采用汉密尔顿抑郁量表(HAMD-17)评价治疗后0,2,4,8周的临床效果;采用药物副反应量表(TESS)评价药品不良反应。结果:治疗4周后,研究组患者的HAMD-17总分及各因子评分均较治疗前显著降低(P<0.05),而对照组患者仅总分、睡眠因子评分明显降低(P<0.05);治疗8周后,两组患者的HAMD-17总分及各因子评分均较治疗前显著降低(P<0.05),而研究组HAMD-17总分、抑郁因子、焦虑/躯体症状因子等评分显著低于对照组(P<0.05)。研究组患者的TESS量表总分及药品不良反应发生率均明显低于对照组(P<0.05)。结论:治疗前行基因多态性检测并实施米那普仑个体化治疗,可快速有效改善抑郁症症状,减少药品不良反应。 展开更多
关键词 adra2a基因 MDGA2基因 基因多态性 米那普仑 抑郁症 个体化治疗
原文传递
ADRA2A(rs1800544)基因多态性在胃肠镜检查中对右美托咪定镇静效果的影响 被引量:1
2
作者 冯靖 鲍彩云 高淑芹 《临床和实验医学杂志》 2022年第21期2345-2350,共6页
目的观察ADRA2A(rs1800544)基因多态性在胃肠镜检查中对右美托咪定镇静效果的影响,初步探讨右美托咪定镇静效果个体差异的遗传学机制。方法前瞻性选取2020年7月至2021年10月在秦皇岛市中医医院门诊行消化道内镜科检查的125例患者。术前... 目的观察ADRA2A(rs1800544)基因多态性在胃肠镜检查中对右美托咪定镇静效果的影响,初步探讨右美托咪定镇静效果个体差异的遗传学机制。方法前瞻性选取2020年7月至2021年10月在秦皇岛市中医医院门诊行消化道内镜科检查的125例患者。术前采集所有研究对象外周静脉血,采用PCR-RFLP法进行ADRA2A启动子区域rs1800544基因分型,根据检测结果分为突变纯合型(CC)、突变杂合型(CG)和野生纯合型(GG)。所有患者术前先进行咽部表面麻醉,麻醉完成后开始泵注右美托咪定,负荷剂量0.3μg/kg。从用药开始分别记录所有患者在T1(0 min)、T2(5 min)、T3(10 min)、T4(30 min)、T5(60 min)时刻的心率、平均动脉压(MAP)、血氧饱和度(SpO_(2))等血流动力学指标;采用脑电双频谱指数(BIS)仪监测所有患者BIS值,并根据警觉/镇静评分(OAA/S)标准记录镇静状态评分;比较所有患者术后出现低血压、低血氧、恶心呕吐、头晕、嗜睡、体动等不良反应发生率。结果根据ADRA2A(rs1800544)基因多态性检测报告统计发现,CC型基因48例(38.4%),CG型基因60例(48.0%),GG型基因17例(13.6%)。血流动力学结果显示,3组患者心率、MAP与SpO_(2)在任何时间点差异均无统计学意义(P>0.05);组内比较,与T1时刻相比,在T4、T5时刻心率、MAP值均有所下降,差异均有统计学意义(P<0.05)。BIS结果显示,自T2时刻开始,所有患者的BIS值均开始下降,且在T2、T3、T4、T5时刻,CC组患者的BIS值明显低于CG组和GG组,差异均有统计学意义(P<0.05)。OAA/S评分结果显示,自T3时刻开始,所有患者的OAA/S评分均开始升高,且在T3、T4、T5时刻,CC组患者的OAA/S评分明显高于于CG组和GG组,差异均有统计学意义(P<0.05)。CC组、CG组、GG组不良反应发生率分别为22.92%、23.33%、35.29%,3组之间差异无统计学意义(P>0.05),但CC组分别与CG、GG组相比,不良反应发生率有减少的趋势。结论ADRA2A(rs1800544)基因多态性是造成胃肠镜检查中右美托咪定镇静效果个体差异的遗传因素之一,携带CC型基因的患者对右美托咪定镇静效果更具有敏感性。 展开更多
关键词 adra2a (rs1800544) 基因多态性 胃肠镜 右美托咪定 镇静
暂未订购
ADRA2A-1291C>G和CCK1R-779T>C基因遗传变异与肠易激综合征相关性的Meta分析
3
作者 苑芳芬 杨晓云 《胃肠病学和肝病学杂志》 CAS 2021年第10期1148-1152,共5页
目的探讨α2A肾上腺素能受体(ADRA2A)-1291C>G和胆囊收缩素受体1(CCK1R)-779T>C的多态性与肠易激综合征(irritable bowel syndrome,IBS)的关系。方法利用PubMed、Embase、ISI科学网和万方数据库的在线网站,在不限制语言的情况下,... 目的探讨α2A肾上腺素能受体(ADRA2A)-1291C>G和胆囊收缩素受体1(CCK1R)-779T>C的多态性与肠易激综合征(irritable bowel syndrome,IBS)的关系。方法利用PubMed、Embase、ISI科学网和万方数据库的在线网站,在不限制语言的情况下,检索1996年6月至2019年5月的相关文献。结果ADRA2A-1291C>G的C等位基因和CCK1R-779T>C的T等位基因与IBS发病风险的增加密切相关。亚组分析表明,ADRA2A-1291C>G增加了显性模型中IBS-C(CC vs GG+CG:OR=1.38,95%CI:1.00~1.90)和IBS-D(CC vs GG+CG:OR=1.50,95%CI:1.06~2.14)的风险。结论ADRA2A-1291C>G的C等位基因与CCK1R-779T>C的T等位基因密切相关,提示IBS的危险性增加。为了验证其关联性,还需要更大的样本进行进一步的研究。 展开更多
关键词 肠易激综合征 adra2a-1291C>G CCK1R-779T>C META分析
暂未订购
人类情绪记忆的行为与神经遗传学研究进展述评 被引量:2
4
作者 邹吉林 周仁来 《心理科学》 CSSCI CSCD 北大核心 2013年第4期1004-1008,共5页
情绪记忆及其增强效应存在广泛的个体差异,这种个体差异可能有其神经与遗传基础。近来的行为遗传学与神经遗传学证实人类ADRA2B基因缺失突变以及BDNF Val66Met基因的多态性与情绪记忆增强及其神经机制的个体差异相联系。本文重点介绍与... 情绪记忆及其增强效应存在广泛的个体差异,这种个体差异可能有其神经与遗传基础。近来的行为遗传学与神经遗传学证实人类ADRA2B基因缺失突变以及BDNF Val66Met基因的多态性与情绪记忆增强及其神经机制的个体差异相联系。本文重点介绍与人类情绪记忆相关的这两种基因,梳理了行为与神经遗传学研究的最新进展,指出未来应关注更多候选基因,并重视多个脑区之间的交互作用;还应使用情绪面孔刺激探索BDNF Val66Met基因多态性对情绪记忆编码和提取的影响等。 展开更多
关键词 情绪记忆 ADRA2B BDNF 基因多态性 突变 杏仁核
原文传递
Association of α_(2A)-Adrenergic Receptor Genetic Variants with Platelet Reactivity in Chinese Patients on Dual Antiplatelet Therapy Undergoing Percutaneous Coronary Intervention 被引量:1
5
作者 SONG Ying TANG Xiao Fang +6 位作者 YAO Yi HE Chen XU Jing Jing WANG Huan Huan GAO Zhan WANG Miao YUAN Jin Qing 《Biomedical and Environmental Sciences》 SCIE CAS CSCD 2017年第12期898-906,共9页
Objective The alpha 2A-adrenergic receptor gene (ADRA2A) polymorphism in individuals antiplatelet response to sympathetic stimulation. The aim of this study was to investigate ADRA2A variants on platelet reactivity ... Objective The alpha 2A-adrenergic receptor gene (ADRA2A) polymorphism in individuals antiplatelet response to sympathetic stimulation. The aim of this study was to investigate ADRA2A variants on platelet reactivity in Chinese patients on dual antiplatelet therapy undergoing percutaneous coronary intervention (PCI). modifies the the effect of (DAPT) after Methods From March 2011 to March 2013, 1,024 patients were enrolled in this prospective, single-center, observational study in China. Four single nucleotide polymorphisms (SNPs) of ADRA2A gene (rs11195419, rs3750625, rs13306146, and rs553668) and CYP2C19^*2 were detected by ligase detection reaction (LDR), and adenosine diphosphate (ADP) inhibition was detected by thromboelastography (TEG). Results The minor allele frequencies of ADRA2A SNPs were common. Platelet ADP inhibition was significantly different among patients carrying rs11195419 (adjusted P = 0.022) and rs3750625 (adjusted P = 0.016). The homozygous allele carriers had the lowest ADP inhibition. However, ADP inhibition was not significantly different in rs553668 and rs13306146. At the multivariate analysis, rs11195419 (P = 0.033), rs3750625 (P = 0.020) and CYP2C19"2 (P = 0.002) were independent predictors of ADP inhibition. Subgroups analysis based on sex showed rs11195419 (P = 0.003) and rs3750625 (P = 0.002) were significantly associated with ADP inhibition in males, but not in females. Conclusion ADRA2A genetic variations were associated with ADP-induced platelet aggregation during DAPT in Chinese patients undergoing PCI, and the effect was particularly more pronounced in males. 展开更多
关键词 adra2a Platelet function POLYMORPHISMS Dual antiplatelet therapy Percutaneouscoronary intervention
暂未订购
ADRA2B gene insertion/deletion polymorphism and artery compliance 被引量:1
6
作者 ZHANG Hai-feng LI Xin-li +7 位作者 XIE Si-feng ZHU Jian WANG Zhen-zhen LIANG Li-rong CAO Ke-jiang DE Wei YUAN Li HUANG Jun 《Chinese Medical Journal》 SCIE CAS CSCD 2005年第21期1797-1802,共6页
Background The ADRA2B gene insertion/deletion (I/D) polymorphism is associated with various cardiovascular and metabolic phenotypes. Large (C1) and small (C2) artery compliance, assessed by pulse wave analysis, ... Background The ADRA2B gene insertion/deletion (I/D) polymorphism is associated with various cardiovascular and metabolic phenotypes. Large (C1) and small (C2) artery compliance, assessed by pulse wave analysis, is considered as sensitive markers or risk factors for cardiovascular disease. Therefore whether the ADRA2B I/D polymorphism is associated with CI and C2 need to be investigated. Methods A total of 227 men and 243 women were enrolled in a Chinese family-based study. C1 and C2 were measured by pulse wave analysis. ADRA2B genotypes were determined by polymerase chain reaction. Statistical methods included generalized estimation equations and quantitative transmission disequilibrium test. Results The II (31.9%), ID (46.8%) and DD (21.3%) genotype frequencies were in Hardy-Weinberg equilibrium (P = 0. 73 ). The covariates selected by stepwise regression for C1 and C2 were age, systolic pressure and gender. The population based association analysis showed that C1 and C2 were not associated with ADRA2B genotype both before (C1 : P =0. 28; C2: P =0. 27) and after (C1 : P =0. 58; C2: P =0. 18) the adjustment. The family-based analyses of 128 informative offspring showed that transmission of the D-allele was not associated with C1 orC2, both before (CI: P=0.42; C2: P=0.85) and after (CI: P=0.31; C2: P= 0. 82) the adjustment. Conclusion The study do not support that the ADRA2B gene I/D polymorphism has a major gene effect on C1 or C2 in the Chinese population of current sample size. 展开更多
关键词 large artery compliance small artery compliance ADRA2B gene
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部